Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms.
Raziyeh SalamiMarziyeh SalamiAlireza MafiOmid VakiliZatollah AsemiPublished in: Cell communication and signaling : CCS (2022)
Glioblastoma multiforme (GBM), as a deadly and almost incurable brain cancer, is the most invasive form of CNS tumors that affects both children and adult population. It accounts for approximately half of all primary brain tumors. Despite the remarkable advances in neurosurgery, radiotherapy, and chemotherapeutic approaches, cell heterogeneity and numerous genetic alterations in cell cycle control, cell growth, apoptosis, and cell invasion, result in an undesirable resistance to therapeutic strategies; thereby, the median survival duration for GBM patients is unfortunately still less than two years. Identifying new therapeutics and employing the combination therapies may be considered as wonderful strategies against the GBM. In this regard, circular RNAs (circRNAs), as tumor inhibiting and/or stimulating RNA molecules, can regulate the cancer-developing processes, including cell proliferation, cell apoptosis, invasion, and chemoresistance. Hereupon, these molecules have been introduced as potentially effective therapeutic targets to defeat GBM. The current study aims to investigate the fundamental molecular and cellular mechanisms in association with circRNAs involved in GBM pathogenesis. Among multiple mechanisms, the PI3K/Akt/mTOR, Wnt/β-catenin, and MAPK signaling, angiogenic processes, and metastatic pathways will be thoroughly discussed to provide a comprehensive understanding of the role of circRNAs in pathophysiology of GBM. Video Abstract.
Keyphrases
- cell proliferation
- cell cycle
- papillary thyroid
- end stage renal disease
- oxidative stress
- single cell
- pi k akt
- signaling pathway
- stem cells
- squamous cell carcinoma
- chronic kidney disease
- ejection fraction
- epithelial mesenchymal transition
- radiation therapy
- early stage
- cell death
- newly diagnosed
- small molecule
- cell migration
- genome wide
- multiple sclerosis
- endoplasmic reticulum stress
- resting state
- bone marrow
- cell therapy
- childhood cancer
- patient reported outcomes
- locally advanced
- copy number
- cancer stem cells
- cerebral ischemia